Abstract Chemoresistance remains a major challenge in the treatment of triple-negative breast cancer (TNBC). However, the mechanisms underlying chemoresistance remain poorly understood. In this study, we identified that higher levels of Rhomboid-Like 2 (RHBDL2) expression were associated with chemoresistance and poor prognosis in patients with TNBC.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Dingye
Contact Dingye, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack